Ahmet Barış Aydın

Ahmet Barış Aydın

Auto-generated profile, based on publicly available information

Ahmet Barış Aydın

Department of Urology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Türkiye.

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 August 2025 in Journal of Pediatric Surgery
Verified
Journal Article
Closed access
TOTayfun Oktar
Tayfun Oktar
ISIsmail Selvi
Ismail Selvi
MDMuhammet İrfan Dönmez
Muhammet İrfan Dönmez
BABarış Aydın
Barış Aydın
ABAbubekir Böyük
Abubekir Böyük
OZOrhan Ziylan
Orhan Ziylan

27 August 2024 in International Journal Of Impotence Research
Verified
Journal Article
Closed access
PDF file
ISIsmail Selvi
Ismail Selvi
MDM. İrFan Dönmez
M. İrFan Dönmez
AAAhmet Barış Aydın
Ahmet Barış Aydın
TOTayfun Oktar
Tayfun Oktar
OZOrhan Ziylan
Orhan Ziylan

10 May 2025 in International Journal of Urology
Verified
Journal Article
Closed access
OZOrhan Ziylan
Orhan Ziylan
ISIsmail Selvi
Ismail Selvi
MDMuhammet İrfan Dönmez
Muhammet İrfan Dönmez
AAAhmet Barış Aydın
Ahmet Barış Aydın
TOTayfun Oktar
Tayfun Oktar

31 March 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
MGMehmet Gurcan
Mehmet Gurcan
YAYasin Ates
Yasin Ates
MEMert Emre Erden
Mert Emre Erden
RERifat Burak Ergül
Rifat Burak Ergül
AAAhmet Baris Aydin
Ahmet Baris Aydin
OSOner Sanli
Oner Sanli
Background: Transperineal magnetic resonance (MRI)/ultrasound (US) fusion-guided prostate biopsy has emerged as a promising alternative to the transrectal approach by improving lesion targeting and reducing infectious complications. However, real-world data addressing factors that influence the detection of clinically significant prostate cancer (csPCa), including imaging characteristics and procedural experience, remain limited. Objective: To evaluate the diagnostic performance, safety profile, and independent predictors of csPCa detection in patients who underwent transperineal MR/US fusion-guided prostate biopsy, with particular emphasis on PIRADS category, prostate-specific antigen (PSA) level, and procedural learning curve. Methods: In this study, patient data were prospectively recorded in a routinely maintained institutional database, while the present analysis was conducted retrospectively. A total of 136 patients with clinical suspicion of prostate cancer—defined as elevated prostate-specific antigen (PSA), abnormal digital rectal examination, or PIRADS ≥3 on multiparametric MRI—underwent transperineal MR/US fusion-guided biopsy between January 2023 and October 2024. Results: Prostate cancer was detected in 45.5% of patients, whereas csPCa was identified in 32.3%. The PIRADS category emerged as the strongest independent predictor of csPCa detection, with PIRADS-5 lesions showing a significantly greater likelihood of csPCa than PIRADS-3 lesions (OR 6.70, p = 0.006). The PSA level was also independently associated with csPCa detection (OR 1.06 per ng/mL increase, p = 0.033). Although csPCa detection rates increased across learning curve groups, procedural experience was not an independent predictor after adjustment. The procedure demonstrated a favorable safety profile, with a low rate of infectious and noninfectious complications despite minimal use of antibiotic prophylaxis. The multivariable model showed moderate explanatory power and acceptable overall classification accuracy. Conclusions: Transperineal MR/US fusion-guided prostate biopsy provides reliable detection of clinically significant prostate cancer with a low complication rate and consistent performance across different stages of institutional experience. The PIRADS category and PSA level remain key determinants of csPCa detection, supporting the integration of MRI-based risk stratification into contemporary prostate cancer diagnostic methods.

21 April 2026 in World Journal of Urology
Verified
Journal Article
Closed access
AAAhmet Baris Aydin
Ahmet Baris Aydin
GGGuven Gunver
Guven Gunver
IGİsMail Taha Gürlek
İsMail Taha Gürlek
SYSude Yarar
Sude Yarar
FÖFaruk Özcan
Faruk Özcan
TTTzevat Tefik
Tzevat Tefik

30 September 2026 in Endouroloji Bulteni
Verified
Journal Article
Closed access
RERifat Burak Ergül
Rifat Burak Ergül
FAFeyzi Arda Atar
Feyzi Arda Atar
AKAhmet Sinan Kabakci
Ahmet Sinan Kabakci
ZTZafer Tokatlı
Zafer Tokatlı
AAAhmet Barış Aydın
Ahmet Barış Aydın
TTTzevat Tefik
Tzevat Tefik
Objective: Robotic-assisted ureteroscopy is increasingly adopted in endourology. We aimed to evaluate the feasibility and safety of the Avicenna Roboflex® Urology system (Elmed, Ankara, Turkey) compared with conventional ureteroscopy in a porcine model.Materials and Methods: The Avicenna Roboflex® platform was compared with conventional ureteroscopy in a live porcine model (n = 6) in the supine lithotomy position. Two experienced endourologists assessed task performance using Likert scales (1–4) for accuracy/workaround and ease of completion. Intraoperative events and ureteral injury were evaluated using the post-ureteroscopic lesion scale (PULS, 0–5). Histopathological assessment of tissue samples was performed by a blinded pathologist. Paired comparisons were performed using the 2-sided Wilcoxon signed-rank test, with p < 0.05 considered statistically significant.Results: A total of 12 ureteroscopic procedures (6 conventional, 6 robotic) were completed without intraoperative complications. Histopathological analysis revealed no significant differences between groups, with minimal epithelial loss observed only in the proximal ureter. Task performance scores were comparable between groups; however, the robotic system showed a trend toward improved ease in flexible ureteroscope insertion and simulated stone removal. PULS scores were low and similar in both groups.Conclusion: The Avicenna Roboflex® system demonstrated procedural feasibility and an acute tissue safety profile comparable to conventional ureteroscopy in this porcine model. Given the exploratory nature and small sample size of the study, these findings should be considered preliminary and require validation in adequately powered studies.